ubuvuzi butera imbere mu kuvura kanseri y'ibihaha

Iterambere ryokuvura Kanseri yibihaha Iyi ngingo iratanga incamake yuzuye yibimaze kugerwaho nubushakashatsi bukomeje gukorwa mu kuvura kanseri y'ibihaha, gushakisha uburyo bushya bwo kuvura no gutera imbere biteza imbere umusaruro w'abarwayi. Tuzasuzuma uburyo bugamije kuvura, ubudahangarwa bw'umubiri, hamwe n'ubuhanga bwo kubaga udushya, twerekana imikorere n'aho bigarukira. Amakuru yatanzwe agenewe intego zamakuru kandi ntagomba gufatwa nkinama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa ku buzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa ubuvuzi.

Ubuvuzi bugenewe: Ubuvuzi bwuzuye mubikorwa

Tyrosine Kinase Inhibitor (TKIs)

Tyrosine kinase inhibitor (TKIs) ni urwego rwibiyobyabwenge byibasira ihinduka ryimiterere ya kanseri yibihaha, bikabuza gukura no gukwirakwira. TKI zitandukanye zirahari, buriwese yagenewe intego yihariye ihinduka nka EGFR, ALK, ROS1, na BRAF. Guhitamo TKI yihariye biterwa na genetique yibibyimba, bigenwa na biopsy. Mugihe TKIs yazamuye cyane ibisubizo kubarwayi bafite ihindagurika ryihariye, kurwanya birashobora gutera imbere mugihe. Ubushakashatsi bukomeje guteza imbere ibisekuruza bizaza TKI kugirango tuneshe iyi myigaragambyo.

Ubundi buryo bwo kuvura

Kurenga TKIs, ubundi buryo bwo kuvura bugaragara. Muri byo harimo ibiyobyabwenge byibanda ku zindi nzira zerekana ko kanseri ikura kandi ikabaho. Iterambere ryiyi miti igamije kwerekana iterambere rigaragara muri ubuvuzi butera imbere mu kuvura kanseri y'ibihaha, kwemerera ubuvuzi bwihariye bushingiye kumiterere yihariye yumurwayi. Ubundi bushakashatsi burakomeje kugirango hamenyekane intego nshya no kunoza imikorere n’umutekano byiyi miti.

Immunotherapy: Gukoresha imbaraga za sisitemu ya Immune

Inhibitori ya Immune (ICIs)

Immune igenzura (ICIs) ni urwego rwibiyobyabwenge rukora muguhagarika poroteyine zibuza umubiri kwirinda indwara ya kanseri. Izi inhibitor zirekura umubiri ubwazo ubudahangarwa bwo kurwanya kanseri. Ibiyobyabwenge nka pembrolizumab na nivolumab byagaragaje intsinzi idasanzwe mu kuvura ubwoko bumwe na bumwe bwa kanseri y'ibihaha, cyane cyane abafite imvugo ya PD-L1. Ariko, ICI irashobora kandi gutera ingaruka zikomeye, bisaba gukurikirana no gucunga neza. Ubushakashatsi burimo gukorwa bwibanze ku kunoza imikorere n’umutekano bya ICI no kumenya biomarkers kugirango hamenyekane abarwayi bazungukira byinshi muri ubwo buvuzi.

Ubundi Ubudahangarwa

Umwanya wo gukingira indwara urenze ICI. Ubundi buryo, burimo kuvura ingirabuzimafatizo (nka CAR T-selile therapy), burimo gukorwaho iperereza kandi bwerekana amasezerano mubice byihariye by’abarwayi ba kanseri y'ibihaha. Gutezimbere no kunonosora izi ngamba zo gukingira byerekana ibyingenzi ubuvuzi butera imbere mu kuvura kanseri y'ibihaha, gutanga ibyiringiro bishya kubarwayi bafite kanseri igoye-kuvura. Iterambere rikunze kuganirwaho mubinyamakuru byubuvuzi ndetse no mu nama nkizakirwa n’imiryango iharanira ubushakashatsi bwa kanseri.

Amajyambere yo kubaga hamwe nubuhanga butagaragara

Kubaga Robo

Kubaga bifashwa na robo byahinduye kubaga kanseri y'ibihaha, bitanga ibisobanuro birambuye kandi byoroshye ugereranije no kubaga gakondo. Ubu buhanga butera cyane butera uduce duto, kugabanya ububabare, gutakaza amaraso make, nigihe cyo gukira vuba kubarwayi. Ikoreshwa rya robo ryongereye ubushobozi bwo kubaga ibihaha bigoye, harimo lobectomie na pneumonectomies, ku barwayi bashobora kuba batari abakandida kuri ubwo buryo mbere. Ibi byerekana iterambere ryinshi mubuzima bwiza kubarwayi ba kanseri yibihaha.

Ubuvuzi bwa stereotactique yumubiri (SBRT)

Ubuvuzi bwa stereotactique yumubiri (SBRT) butanga urugero rwinshi rwimirasire mubice bito, byibasiwe nibihaha, bikagabanya kwangirika kwinyama nzima. Ubu buhanga bugirira akamaro cyane cyane abarwayi barwaye kanseri y'ibihaha hakiri kare cyangwa abatari abakandida kubagwa. SBRT yerekanye ibisubizo bigereranywa no kubaga indwara zo hambere ku barwayi batoranijwe. Iterambere rihoraho mu ikoranabuhanga ryimirasire irusheho kunoza neza imikorere ya SBRT.

Icyerekezo kizaza mukuvura kanseri yibihaha

Ubushakashatsi bukomeje kwibanda ku bintu byinshi by'ingenzi: kunoza uburyo bwo gutahura hakiri kare, guteza imbere uburyo bwiza bwo kuvura no kutagira uburozi, no kwivuza bishingiye ku miterere y'abarwayi ku giti cyabo. Ubushakashatsi bwakozwe kuri genomic ya kanseri yibihaha, hamwe niterambere ryubwenge bwubuhanga no kwiga imashini, bidusezeranya guhindura uko twegera ubuvuzi butera imbere mu kuvura kanseri y'ibihaha mu myaka iri imbere.

Uburyo bwo kuvura	Ibyiza	Ibibi
TKIs	Igikorwa kigamije, kunoza ibisubizo kuri mutation yihariye	Iterambere ryo kurwanya, ingaruka zishobora kubaho
ICI	Gukoresha sisitemu yumubiri, ibisubizo biramba mubarwayi bamwe	Ingaruka zijyanye n'ubudahangarwa, ntabwo zifite akamaro kubarwayi bose
Kubaga Robo	Ntibisanzwe, ububabare buke, gukira vuba	Ntibikwiriye abarwayi bose, bisaba ibikoresho kabuhariwe
SBRT	Gutanga imirasire yuzuye, byibasiye cyane indwara zintangiriro	Ingaruka zishobora kubaho, ntabwo zikwiranye nindwara zose

Kubindi bisobanuro bijyanye no kuvura kanseri y'ibihaha n'ubushakashatsi, nyamuneka sura Shandong Baofa Ikigo Cyubushakashatsi Kanseri urubuga. Ibisobanuro byatanzwe muriyi ngingo ni kubumenyi rusange nintego zamakuru gusa, kandi ntabwo bigize inama zubuvuzi. Buri gihe ujye ubaza inzobere mu by'ubuzima zujuje ibisabwa kugira ngo zisuzume kandi zivure indwara iyo ari yo yose.

Inshingano: Aya makuru agenewe intego zuburezi gusa kandi ntagomba gufatwa nkinama zubuvuzi. Nyamuneka saba inzobere mu by'ubuzima zujuje ibyangombwa bijyanye n'ubuzima cyangwa mbere yo gufata ibyemezo byose bijyanye n'ubuzima bwawe cyangwa kwivuza.